Microbot Medical (Germany) Top Insiders
CY9D Stock | EUR 1.43 0.01 0.69% |
Microbot Medical employs about 20 people. The company is managed by 15 executives with a total tenure of roughly 83 years, averaging almost 5.0 years of service per executive, having 1.33 employees per reported executive. Examination of Microbot Medical's management performance can provide insight into the company performance.
Harel Gadot Chairman Chairman of the Board, President, Chief Executive Officer |
Microbot |
Microbot Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.6524) % which means that it has lost $0.6524 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.1989) %, meaning that it generated substantial loss on money invested by shareholders. Microbot Medical's management efficiency ratios could be used to measure how well Microbot Medical manages its routine affairs as well as how well it operates its assets and liabilities.Microbot Medical Workforce Comparison
Microbot Medical is number one stock in number of employees category among its peers. The total workforce of Medical Instruments & Supplies industry is currently estimated at about 13,183. Microbot Medical adds roughly 20.0 in number of employees claiming only tiny portion of all equities under Medical Instruments & Supplies industry.
Microbot Medical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Microbot Medical Price Series Summation is a cross summation of Microbot Medical price series and its benchmark/peer.
Microbot Medical Notable Stakeholders
A Microbot Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Microbot Medical often face trade-offs trying to please all of them. Microbot Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Microbot Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Harel Gadot | Chairman of the Board, President, Chief Executive Officer | Profile | |
David Naim | Chief Financial Officer | Profile | |
Simon Sharon | Chief Technology Officer | Profile | |
Prattipati Laxminarain | Independent Director | Profile | |
Yoav Waizer | Independent Director | Profile | |
Rachel Vaknin | Chief Officer | Profile | |
Tal Wenderow | Independent Director | Profile | |
Yoseph Bornstein | Independent Director | Profile | |
Eyal MD | Chief Board | Profile | |
Aileen Stockburger | Independent Director | Profile | |
MSc MBA | CTO GM | Profile | |
Pr DSc | Scientific CoFounder | Profile | |
Eyal Morag | Chief Medical Officer | Profile | |
Scott Burell | Independent Director | Profile | |
Martin Madden | Independent Director | Profile |
About Microbot Medical Management Performance
The success or failure of an entity such as Microbot Medical often depends on how effective the management is. Microbot Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Microbot management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Microbot management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. MICROBOT MEDICAL operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 14 people.
Microbot Medical Workforce Analysis
Traditionally, organizations such as Microbot Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Microbot Medical within its industry.Microbot Medical Manpower Efficiency
Return on Microbot Medical Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 565.6K | |
Net Loss Per Executive | 754.2K |
Complementary Tools for Microbot Stock analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |